2.1.1.137 C10S activtiy similar to wild-type 757684 2.1.1.137 C10S/C11S/C193S/C268S mutant dispays activity 757684 2.1.1.137 C11S activity similar to wild-type 757684 2.1.1.137 C145S loss of catalytic activity 757684 2.1.1.137 C165S inactive 721074 2.1.1.137 C174A the mutation leads to loss of As(III) methylation 718946 2.1.1.137 C186S mutation abolishes the capability of As(III) methylation 757317 2.1.1.137 C193S activity similar to wild-type 757684 2.1.1.137 C195S loss of catalytic activity 757684 2.1.1.137 C210S inactive 721074 2.1.1.137 C224A the mutation leads to loss of As(III) methylation 718946 2.1.1.137 C238S mutation abolishes the capability of As(III) methylation 757317 2.1.1.137 C250S the mutation favors S-adenosyl-L-methionine binding to the enzyme 735126 2.1.1.137 C268S activity similar to wild-type 757684 2.1.1.137 C271S the mutation does not affect the activity and structure of the enzyme 719012 2.1.1.137 C334S the mutation decreases the enzymatic turnover and changes the conformation of the enzyme 719012 2.1.1.137 C360S the mutation decreases the enzymatic turnover and changes the conformation of the enzyme 719012 2.1.1.137 C375S the mutation does not affect the activity and structure of the enzyme 719012 2.1.1.137 C44A mutant is unable to methylate arsenic(III) but retains the ability to methylate methylarsenate 755717 2.1.1.137 C44A/C72A mutant is unable to methylate arsenic(III) but retains the ability to methylate methylarsenate 755717 2.1.1.137 C59S mutation abolishes the capability of As(III) methylation 757317 2.1.1.137 C72A the mutation leads to loss of As(III) methylation, but still shows trivalent methylarsenate methylation 718946 2.1.1.137 C72S the mutant is completely inactive 719012 2.1.1.137 D102N inactive 733865 2.1.1.137 D102P inactive 733865 2.1.1.137 D150N the mutant shows reduced activity compared to the wild type enzyme 733865 2.1.1.137 D150P inactive 733865 2.1.1.137 D76N inactive 733865 2.1.1.137 D76P inactive 733865 2.1.1.137 D84N inactive 733865 2.1.1.137 D84P inactive 733865 2.1.1.137 G134A the mutant’s activity is seriously impaired compared with that of wild type 733425 2.1.1.137 G60A inactive 733425 2.1.1.137 G80A inactive 733425 2.1.1.137 G82A the mutant’s activity is seriously impaired compared with that of wild type 733425 2.1.1.137 I101A inactive 733425 2.1.1.137 L160A inactive 733425 2.1.1.137 L77A the mutant’s activity is seriously impaired compared with that of wild type 733425 2.1.1.137 M287T a naturally occurring T/C polymorphism in AS3MT among Japanese, Koreans, Chinese, Mongolians, Uygurs, Tibetans, Tamangs, Tamils, Sinhalese, Turks, Ovambos, Ghanaians, and Xhosas. Xhosas have the highest 287T frequency 700331 2.1.1.137 M287T genotype distribution and allele frequencies of M287T in Ovambo, Turkish, Mongolian, Korean, and Japanese populations , the mutation frequencies in Asian populations are relatively lower than those of African and Caucasian populations, the frequencies of mutation in the Mongolian, Korean, and Japanese populations, overview 701300 2.1.1.137 M287T in the absence of glutathione, the mutant shows decreased Vmax and Km for arsenite and increased Vmax and Km for methylarsonate compared to the wild type enzyme 721075 2.1.1.137 M287T naturally occuring mutant 697642 2.1.1.137 M287T the mutation is associated with an increased percentage of monomethylated arsenic in urine 718712 2.1.1.137 M287T the substitution results in an increase in the capacity of the first step of methylation, leading to an increase in the percentage of urinary methylarsonate, but not the second step of methylation 733451 2.1.1.137 additional information an exon-4 and -5 skipping (DELTA4,5) truncated mutant form does not convert arsenite to monomethylarsonate or dimethylarsinic acid 718748 2.1.1.137 N155A inactive 733425 2.1.1.137 R57A the mutant's activity is seriously impaired compared with that of wild type 733425 2.1.1.137 R83A the mutant’s activity is seriously impaired compared with that of wild type 733425 2.1.1.137 S81A the mutant’s activity is seriously impaired compared with that of wild type 733425 2.1.1.137 T104A the mutant’s activity is seriously impaired compared with that of wild type 733425 2.1.1.137 V157A the mutant’s activity is seriously impaired compared with that of wild type 733425 2.1.1.137 V161A the mutant’s activity is seriously impaired compared with that of wild type 733425 2.1.1.137 Y135A the mutant’s activity is seriously impaired compared with that of wild type 733425 2.1.1.137 Y58A the mutant’s activity is seriously impaired compared with that of wild type 733425 2.1.1.137 Y70W the mutant exhibits metalloid binding 718946